• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCR4上调的间充质干细胞在大鼠肾移植模型中的保护作用

Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model.

作者信息

Cao Zhiqiang, Zhang Geng, Wang Fuli, Liu Hongbao, Liu Long, Han Yaling, Zhang Jian, Yuan Jianlin

机构信息

Department of Urinary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

出版信息

PLoS One. 2013 Dec 30;8(12):e82949. doi: 10.1371/journal.pone.0082949. eCollection 2013.

DOI:10.1371/journal.pone.0082949
PMID:24386129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3875425/
Abstract

The homing of mesenchymal stem cells to injured tissue, which is important for the correction of conditions such as ischemia-reperfusion injury (IRI) and immunolesions, has been performed previously, but with poor efficiency. Substantial improvements in engraftment are required to derive clinical benefits from MSC transplantation. Chemokines are the most important factors that control cellular migration. Stromal derived factor-1 (SDF-1) is up-regulated during tissue/organ ischemia damage, and its cognate receptor, chemokine receptor 4 (CXCR4), is involved in stem cell migration. The aim of our study was to investigate CXCR4 expression in MSCs and to validate both its role in mediating migration to transplanted kidneys and its immunoregulatory effects in renal protection. Specifically, the present study was designed to investigate the short-term tissue homing of MSCs carrying genetically modified CXCR4 in a rat renal transplantation model. We tested the hypothesis that MSCs with CXCR4 over-expression can more efficiently regulate immunological reactions. Lentiviral vectors were used to over-express CXCR4 or to introduce a short hairpin ribonucleic acid (shRNA) construct targeting endogenous CXCR4 in rat MSCs. MSCs were labeled with enhanced green fluorescent protein (eGFP). After cell sorting, recipient kidneys were regionally perfused; recipient animals were injected with transduced MSCs, native MSCs, or PBS via tail vein following renal transplantation; and the effects of MSC injection were observed.

摘要

间充质干细胞归巢至损伤组织对纠正诸如缺血再灌注损伤(IRI)和免疫损伤等病症很重要,此前已有相关研究,但效率较低。为了从间充质干细胞移植中获得临床益处,需要大幅提高其植入效率。趋化因子是控制细胞迁移的最重要因素。基质细胞衍生因子-1(SDF-1)在组织/器官缺血损伤时上调,其同源受体趋化因子受体4(CXCR4)参与干细胞迁移。我们研究的目的是调查间充质干细胞中CXCR4的表达,并验证其在介导向移植肾迁移中的作用及其在肾脏保护中的免疫调节作用。具体而言,本研究旨在调查携带基因修饰CXCR4的间充质干细胞在大鼠肾移植模型中的短期组织归巢情况。我们检验了CXCR4过表达的间充质干细胞能更有效地调节免疫反应这一假设。慢病毒载体用于在大鼠间充质干细胞中过表达CXCR4或引入靶向内源性CXCR4的短发夹核糖核酸(shRNA)构建体。间充质干细胞用增强型绿色荧光蛋白(eGFP)标记。细胞分选后,对受体肾脏进行区域灌注;肾移植后,经尾静脉给受体动物注射转导的间充质干细胞、天然间充质干细胞或磷酸盐缓冲液(PBS);并观察间充质干细胞注射的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/095d146594f2/pone.0082949.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/14ee11a4e259/pone.0082949.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/d54cb845c7e1/pone.0082949.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/d13a93d8ac67/pone.0082949.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/620501d21ed0/pone.0082949.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/9bce9d493397/pone.0082949.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/99fe838e4788/pone.0082949.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/095d146594f2/pone.0082949.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/14ee11a4e259/pone.0082949.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/d54cb845c7e1/pone.0082949.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/d13a93d8ac67/pone.0082949.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/620501d21ed0/pone.0082949.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/9bce9d493397/pone.0082949.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/99fe838e4788/pone.0082949.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2041/3875425/095d146594f2/pone.0082949.g007.jpg

相似文献

1
Protective effects of mesenchymal stem cells with CXCR4 up-regulation in a rat renal transplantation model.CXCR4上调的间充质干细胞在大鼠肾移植模型中的保护作用
PLoS One. 2013 Dec 30;8(12):e82949. doi: 10.1371/journal.pone.0082949. eCollection 2013.
2
Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI).基质衍生因子-1/细胞表面趋化因子受体 4 轴在系统性移植的人羊膜间充质干细胞(hAD-MSCs)归巢至化疗诱导的卵巢早衰(POI)大鼠卵巢中的重要作用。
Stem Cell Res Ther. 2022 Feb 23;13(1):79. doi: 10.1186/s13287-022-02759-6.
3
Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.过表达 C-X-C 趋化因子受体 4 的间充质干细胞可改善小体积肝移植物的早期肝再生。
Liver Transpl. 2013 Feb;19(2):215-25. doi: 10.1002/lt.23577.
4
Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.转化生长因子-β1促进骨髓间充质干细胞在肾缺血再灌注损伤中的归巢。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12368-78. eCollection 2015.
5
The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury.SDF-1-CXCR4/CXCR7 轴在低氧预处理骨髓间充质干细胞治疗肾缺血/再灌注损伤中的作用。
PLoS One. 2012;7(4):e34608. doi: 10.1371/journal.pone.0034608. Epub 2012 Apr 12.
6
Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.间质干细胞 Cxcr4 基因在受照射小鼠中的过表达增加了这些细胞的归巢能力。
Cell Biochem Biophys. 2013;67(3):1181-91. doi: 10.1007/s12013-013-9632-6.
7
Stem cell attraction via SDF-1α expressing fat tissue grafts.通过表达 SDF-1α 的脂肪组织移植物吸引干细胞。
J Biomed Mater Res A. 2013 Jul;101(7):2067-74. doi: 10.1002/jbm.a.34512. Epub 2012 Dec 22.
8
Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke.骨髓间充质干细胞中 CXCR4 的过表达促进中风大鼠模型中的迁移、神经保护和血管生成。
J Neurol Sci. 2012 May 15;316(1-2):141-9. doi: 10.1016/j.jns.2012.01.001. Epub 2012 Jan 26.
9
Injectable hydrogel delivery plus preconditioning of mesenchymal stem cells: exploitation of SDF-1/CXCR4 axis toward enhancing the efficacy of stem cells' homing.可注射水凝胶递送与间充质干细胞预处理:利用SDF-1/CXCR4轴提高干细胞归巢效果
Cell Biol Int. 2016 Jul;40(7):730-41. doi: 10.1002/cbin.10474. Epub 2016 May 1.
10
The SDF-1/CXCR4 Signaling Pathway Directs the Migration of Systemically Transplanted Bone Marrow Mesenchymal Stem Cells Towards the Lesion Site in a Rat Model of Spinal Cord Injury.在大鼠脊髓损伤模型中,SDF-1/CXCR4信号通路引导全身移植的骨髓间充质干细胞向损伤部位迁移。
Curr Stem Cell Res Ther. 2023;18(2):216-230. doi: 10.2174/1574888X17666220510163245.

引用本文的文献

1
CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro.CXCR4是甲状旁腺激素的一个反应基因,其在体外影响成骨细胞和破骨细胞的功能。
Bone Joint Res. 2025 May 16;14(5):463-476. doi: 10.1302/2046-3758.145.BJR-2024-0167.R1.
2
The Therapeutic Use and Potential of MSCs: Advances in Regenerative Medicine.间充质干细胞的治疗用途与潜力:再生医学进展
Int J Mol Sci. 2025 Mar 27;26(7):3084. doi: 10.3390/ijms26073084.
3
CXCR4 Sorted Adipose-Derived Stem Cells Enhance Their Functional Benefits and Improve Cardiac Function after Myocardial Infarction.

本文引用的文献

1
[Cellular factors of ischemia/reperfusion injury pathogenesis in the renal transplantation].[肾移植中缺血/再灌注损伤发病机制的细胞因素]
Ross Fiziol Zh Im I M Sechenova. 2012 Jul;98(7):906-14.
2
Stem cell therapy in kidney transplantation.肾脏移植中的干细胞治疗。
JAMA. 2012 Jul 11;308(2):130; author reply 130-1. doi: 10.1001/jama.2012.6370.
3
Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury.
CXCR4分选的脂肪来源干细胞增强其功能益处并改善心肌梗死后的心脏功能。
Stem Cells Int. 2022 Aug 23;2022:6714765. doi: 10.1155/2022/6714765. eCollection 2022.
4
Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury.基于间充质干细胞的急性肾损伤治疗的分子机制。
Int J Mol Sci. 2021 Oct 22;22(21):11406. doi: 10.3390/ijms222111406.
5
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease.来源的重要性:不同来源间充质基质细胞在肾脏疾病临床转化中的特性
Front Med (Lausanne). 2021 Sep 20;8:728496. doi: 10.3389/fmed.2021.728496. eCollection 2021.
6
Preconditioned Mesenchymal Stromal Cells to Improve Allotransplantation Outcome.预处理间充质基质细胞以改善同种异体移植的效果。
Cells. 2021 Sep 6;10(9):2325. doi: 10.3390/cells10092325.
7
The Role of CXCL12 in Kidney Diseases: A Friend or Foe?CXCL12在肾脏疾病中的作用:是友还是敌?
Kidney Dis (Basel). 2021 May;7(3):176-185. doi: 10.1159/000514913. Epub 2021 Apr 6.
8
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells.间充质干细胞治疗免疫和炎症性疾病的进展:无细胞产品和人多能干细胞衍生的间充质干细胞的应用。
Stem Cells Transl Med. 2021 Sep;10(9):1288-1303. doi: 10.1002/sctm.21-0021. Epub 2021 May 19.
9
Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation.间充质基质细胞治疗实体器官移植。
Front Immunol. 2021 Feb 10;11:618243. doi: 10.3389/fimmu.2020.618243. eCollection 2020.
10
Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation.预处理是提高肾移植中间充质干细胞效率的有效策略。
Stem Cell Res Ther. 2020 May 24;11(1):197. doi: 10.1186/s13287-020-01721-8.
基因修饰间充质干细胞过表达 CXCR4 和 CXCR7 并不改善这些细胞在实验性急性肾损伤中的归巢和治疗潜能。
Stem Cells Dev. 2012 Nov 1;21(16):2969-80. doi: 10.1089/scd.2011.0588. Epub 2012 Jul 24.
4
The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury.SDF-1-CXCR4/CXCR7 轴在低氧预处理骨髓间充质干细胞治疗肾缺血/再灌注损伤中的作用。
PLoS One. 2012;7(4):e34608. doi: 10.1371/journal.pone.0034608. Epub 2012 Apr 12.
5
Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.自体间充质干细胞诱导治疗活体亲属肾移植:一项随机对照试验。
JAMA. 2012 Mar 21;307(11):1169-77. doi: 10.1001/jama.2012.316.
6
In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.骨髓间充质干细胞在延长冷缺血大鼠肾移植模型中的体内作用。
Transpl Int. 2011 Nov;24(11):1112-23. doi: 10.1111/j.1432-2277.2011.01328.x. Epub 2011 Aug 31.
7
Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression.骨髓间充质干细胞诱导调节性 T 细胞生成和肾移植耐受与吲哚胺 2,3-双加氧酶表达相关。
Transplantation. 2010 Dec 27;90(12):1312-20. doi: 10.1097/TP.0b013e3181fed001.
8
Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation.改变树突状细胞肌动蛋白分布抑制免疫突触:间充质干细胞免疫调节的新途径。
J Immunol. 2010 Nov 1;185(9):5102-10. doi: 10.4049/jimmunol.1001332. Epub 2010 Oct 1.
9
Stem cell technology for the treatment of acute and chronic renal failure.干细胞技术治疗急性和慢性肾衰竭。
Transl Res. 2010 Sep;156(3):161-8. doi: 10.1016/j.trsl.2010.07.005. Epub 2010 Jul 30.
10
Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).间质干细胞疗法在实体器官移植中的进展(MISOT)。
Transplantation. 2010 Jul 27;90(2):124-6. doi: 10.1097/TP.0b013e3181ea4240.